Navigation Links
HLTH Corporation Announces Second Quarter Financial Results
Date:7/30/2009

shares outstanding used in computing net loss attributable to HLTH stockholders per common share: Basic 104.0 104.0 Diluted 108.0 108.0 (a) See Annex A - Explanation of Non-GAAP Financial Measures. (b) Reconciliation of Adjusted EBITDA to consolidated income from continuing operations. (c) Interest expense includes additional non-cash interest expense from the January 1, 2009 adoption of Financial Accounting Standards Board's Staff Position APB Opinion No. 14-1, "Accounting for Convertible Debt Instruments That May Be Settled in Cash Upon Conversion (Including Partial Cash Settlement)." (d) The income tax provision excludes any benefit relating to any reversal in 2009 of the valuation allowance against deferred tax assets. (e) Net income attributable to HLTH stockholders excludes guidance relating to the HLTH's discontinued operations. This table reflects actual income and expense through June 30, 2009 for the "gain on repurchases of convertible notes," "other expenses" and "consolidated loss from discontinued operations" but does not reflect guidance for these items in any future quarter. We do not make projections for these items, although they may recur in future quarters. The above guidance excludes potential reductions in Corporate expenses, reductions in weighted-average shares outstanding, transaction expenses and other impacts of the pending merger of WebMD and HLTH.

ANNEX A

Explanation of Non-GAAP Financial Measures

The accompanying HLTH Corporation press release and financial tables include both financial measures in accordance with U.S. generally accepted accounting p
'/>"/>

SOURCE HLTH Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23

Related medicine news :

1. The ScottCare Corporation Completes Acquisition of Rozinn Electronics, a Leading Manufacturer of Cardiac Diagnostic Products
2. Brooke Franchise Corporation Announces Selected July Results
3. MedThink Communications Retained by NanoBio Corporation
4. EaglePicher Corporation Completes Transaction to Sell EaglePicher Boron, LLC to Ceradyne, Inc. for $69 Million
5. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
6. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
7. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
8. LifeQuest World Corporation Proud Contributor to Dietary Supplement Education Alliance (DSEA)
9. DTI Medical Corporation Announces Reverse Split and Other Corporate Developments
10. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
11. AGA Medical Corporation Receives Approval for the AMPLATZER Muscular Ventricular Septal Defect Occluder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... California (PRWEB) December 25, 2014 Plugin ... of ProFire 5k. A fully customizable business presentation tool ... , “Adding the ProFire 5k business tool, users can ... Christina Austin, CEO of Pixel Film Studios. “ProFire 5k ... and style to add professionalism to a presentation” , ...
(Date:12/25/2014)... AZ (PRWEB) December 25, 2014 Parker ... to outstanding customer service and affordable quality regarding heating, ... area announces recognition in 2014 by the “Queen of ... Sons has earned an impressive reputation over the years ... on a wide range of contractor services for both ...
(Date:12/24/2014)... Epigenetics finds applications in a large ... drug discovery, developmental biology, and research for metabolic and ... the most widely used techniques for the discovery and ... of cancer is rapidly growing worldwide. In 2012, there ... deaths, and 32.6 million people living with cancer (within ...
(Date:12/24/2014)... 2014 Risperdal lawsuit ( http://www.risperdallawsuit2014.com/ ) ... litigation currently underway in Pennsylvania’s Philadelphia Court of Common ... 24, 2014, court documents indicate that 1,183 claims had ... who developed gynecomastia (male breast growth) and other complications ... indicates that this represents an increase of more than ...
(Date:12/24/2014)... 2014 The federal court overseeing ... blood thinner caused life-threatening episodes of internal bleeding ... for the proceeding, Bernstein Liebhard LLP reports. According ... plans to select lawyers to serve as Liaison ... appointing a Plaintiffs’ Steering Committee, which will coordinate ...
Breaking Medicine News(10 mins):Health News:Announcing a new ProFire 5k plugin from Pixel Film Studios for Final Cut Pro X Professionals 2Health News:Parker & Sons Announces Recognition In 2014 By The “Queen Of Clean” For Impressive Contractor Services In Arizona 2Health News:Parker & Sons Announces Recognition In 2014 By The “Queen Of Clean” For Impressive Contractor Services In Arizona 3Health News:Global Epigenetics Market Was Valued at $413.24 Million in 2014 - New Research Report by MarketsandMarkets 2Health News:Global Epigenetics Market Was Valued at $413.24 Million in 2014 - New Research Report by MarketsandMarkets 3Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 2Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 3Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 4Health News:Court Overseeing Federal Xarelto Lawsuits Issues Coordination Order, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal Xarelto Lawsuits Issues Coordination Order, Bernstein Liebhard LLP Reports 3
... Uroplasty, Inc. (Amex:,UPI) announced today that it ... Fourth Annual Equity Conference which will be held ... the Loews Lake Las Vegas Resort, NV.,Dave Kaysen, ... Vice,President and Chief Financial Officer will discuss the ...
... Aug. 11 ,BlueCross BlueShield of Tennessee (BCBS-T) has ... settle allegations of violating the False Claims,Act, the ... Chattanooga, Tenn., operates as Riverbend Government Benefit,Administrators., ... primary,Medicare Part A Fiscal Intermediary for the state ...
... access and practical ... ... for medical professionals, today announced the availability,of PubMed,s MEDLINE abstracts at ... U.S. National Library,of Medicine,s MEDLINE index. SearchMedica,s MEDLINE abstracts link back ...
... Nation Using Caregiverlist.com to Find Quality ... ... nation,s online,destination dedicated to connecting seniors with quality senior care,choices, is ... care services as the caregiving recruitment source for the,industry. Nearly 1,000 ...
... Cardiovascular Disease (GICD) and UCSF have identified a key ... system, the extensive network of arteries, veins, and ... organs. The research, published in the latest issue of ... therapeutic targets for a wide variety of diseases, such ...
... Cincinnati Sub-Zero Medical receives Governor,s 2008 Excellence in Exporting Award (,E-Award,), ... Strickland and Lieutenant Governor Lee Fisher present award to CSZ Chairman ... ... August 11, 2008 -- Cincinnati Sub-Zero (CSZ) Medical, a division of ...
Cached Medicine News:Health News:Uroplasty to Present at the Noble Financial Fourth Annual Equity Conference 2Health News:BlueCross BlueShield of Tennessee to Pay U.S. $2.1 Million to Resolve False Claims Act Allegations 2Health News:SearchMedica.com Connects Medical Professionals With MEDLINE Abstracts 2Health News:Home Care Agencies Staffing Challenge Solved With Caregiverlist.com 2Health News:Gladstone scientists identify single microRNA that controls blood vessel development 2Health News:Gladstone scientists identify single microRNA that controls blood vessel development 3Health News:State of Ohio Recognizes Cincinnati Sub-Zero for Excellence in International Sales 2Health News:State of Ohio Recognizes Cincinnati Sub-Zero for Excellence in International Sales 3
(Date:12/24/2014)... DIEGO , Dec. 24, 2014  Conkwest, ... West, developing the proprietary Natural Killer (NK) cell-line ... that Dr. Patrick Soon-Shiong , NantWorks founder, ... a definitive agreement to purchase approximately $48 million ... connection with the investment, he will be named ...
(Date:12/24/2014)... 23, 2014 PuraMed BioScience®, Inc., (OTC Pink: ... medicinal and healthcare products, announced it received the initial ... hemp-based, advanced headache relief product, for planned distribution to ... Colorado , Washington State , ... the MigraPure H Advanced headache relief gel formulation completed, ...
(Date:12/24/2014)... , December 24, 2014 ... Report on Global Disposable Syringe Industry of ... its online business intelligence library. ... Disposable Syringe Industry is a professional and ... market.  For overview analysis, the report introduces ...
Breaking Medicine Technology:Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 2Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 3Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 4Conkwest Announces $50m In Strategic Investments And Appoints NantWorks Founder, Dr. Patrick Soon-Shiong As Co-Chairman Of The Board 5PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 2PuraMed BioScience Nears Final Stages Needed for Distribution of MigraPure H 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 2World Disposable Syringe Market 2014 Report: China and Regional Analysis 3World Disposable Syringe Market 2014 Report: China and Regional Analysis 4World Disposable Syringe Market 2014 Report: China and Regional Analysis 5
... Athletes Who Have UCL Reconstruction Prior to Being Drafted ... Feb. 28 New research presented at ... Day in Las Vegas suggests that elbow ulnar collateral ... League Baseball (MLB) draft does not increase the risk ...
... -- MannKind Corporation (Nasdaq: MNKD ... new drug application ("NDA") for AFRESA(R), an ultra rapid-acting insulin ... announced, our internal goal was to submit the NDA to ... February. Based on editorial decisions made during the final ...
Cached Medicine Technology:Elbow Ligament Reconstruction Appears Not to Affect Future Professional Advancement in Baseball 2MannKind Updates Status of NDA Submission for AFRESA 2MannKind Updates Status of NDA Submission for AFRESA 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: